TY - JOUR
T1 - Prediction of need for bowel resection in acute superior mesenteric artery occlusion
T2 - A retrospective study of 48 Japanese patients
AU - Watada, Susumu
AU - Obara, Hideaki
AU - Okui, Jun
AU - Hosokawa, Kyosuke
AU - Matsubara, Kentaro
AU - Harada, Hirohisa
AU - Fujimura, Naoki
AU - Fujii, Taku
AU - Shimogawara, Tatsuya
AU - Kitagawa, Yuko
N1 - Funding Information:
Funding: Dr. Kitagawa is Editor‐in‐Chief of ; has received lecture fees from Otsuka Pharmaceutical Factory Inc., Shionogi & Co., Ltd., Nippon Covidien Inc., Ethicon, Inc., Ono Pharmaceutical Co., Ltd., Olympus Corporation, Bristol‐Myers Squibb K.K., AstraZeneca K.K., MSD K.K., Smith & Nephew KK, and Kaken Pharmaceutical Co., Ltd. outside the submitted work; and was supported by grants from Takeda Pharmaceutical Co., Ltd., Chugai Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., Yakult Honsha Co. Ltd., Asahi Kasei Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Tsumura & Co., Kyouwa Hakkou Kirin Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., EA Pharma Co., Ltd., Astellas Pharma Inc., Toyama Chemical Co., Ltd., Medicon Inc., Kaken Pharmaceutical Co., Ltd., Eisai Co., Ltd., Otsuka Pharmaceutical Factory Inc., Teijin Pharma Limited., Nihon Pharmaceutical Co., Ltd., and Nippon Covidien Inc. Annals of Gastroenterological Surgery
Funding Information:
Conflicts of Interest: Dr. Obara is a consultant for Medico's Hirata and a speaker for W. L. Gore & Associates; has received lecture fees from Otsuka Pharmaceutical Factory Inc., Medtronic, Boston Scientific, W. L. Gore & Associates, Bard, and Cook; and was supported by grants from Medtronic Japan Co., Ltd., Japan Blood Products Organization, Taiho Pharmaceutical Co., Ltd., W. L. Gore & Associates, Co., Ltd., Daiichi Sankyo Company, Ltd, Mitsubishi Tanabe Pharma Corporation, Teijin Pharma Limited, Kaken Pharmaceutical Co., Ltd., Novartis Pharma Co., Ltd., JMS Co., Ltd., MSD K.K., Nihon Pharmaceutical Co., Ltd., and Japan Lifeline Co., Ltd.
Publisher Copyright:
© 2022 The Authors. Annals of Gastroenterological Surgery published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Gastroenterology.
PY - 2023/1
Y1 - 2023/1
N2 - Aim: This study aimed to predict cases of acute superior mesenteric artery (SMA) occlusion requiring bowel resection using occlusion site and time from symptom onset to diagnosis at five Japanese institutions. Advances in imaging, endovascular treatment, and perioperative management have improved the clinical outcomes of patients with acute SMA occlusion; however, in clinical practice it remains difficult to effectively determine patients requiring bowel resection. Methods: We retrospectively analyzed the data of 48 patients (mean age: 82.5 y; male: 37.5%) diagnosed with acute SMA occlusion between June 2009 and August 2018. Background data of patients who required and did not require bowel resection were compared. A multivariable predictive model was developed using the time from symptom onset to diagnosis and whether SMA occlusion was proximal, including the origin of the middle colic artery. Results: Fifteen patients (31.3%) died during the hospital stay. Atrial fibrillation (83.3%) was the most common comorbidity. The median time from symptom onset to diagnosis was 13.0 (interquartile range, 4.75–24.0) h. Laparotomy, bowel resection, and thrombus embolectomy were performed in 41 (85.4%), 26 (54.2%), and 21 (43.8%) patients, respectively. A logistic regression model achieved 78.6% sensitivity in predicting cases not requiring bowel resection. Proximal occlusion was significantly associated with the requirement for bowel resection (P =.039). Conclusion: The time from symptom onset to diagnosis and occlusion site contributed to high sensitivity in determining the need for bowel resection in patients with acute SMA occlusion. Further prospective studies are warranted to investigate the clinical impact of this model.
AB - Aim: This study aimed to predict cases of acute superior mesenteric artery (SMA) occlusion requiring bowel resection using occlusion site and time from symptom onset to diagnosis at five Japanese institutions. Advances in imaging, endovascular treatment, and perioperative management have improved the clinical outcomes of patients with acute SMA occlusion; however, in clinical practice it remains difficult to effectively determine patients requiring bowel resection. Methods: We retrospectively analyzed the data of 48 patients (mean age: 82.5 y; male: 37.5%) diagnosed with acute SMA occlusion between June 2009 and August 2018. Background data of patients who required and did not require bowel resection were compared. A multivariable predictive model was developed using the time from symptom onset to diagnosis and whether SMA occlusion was proximal, including the origin of the middle colic artery. Results: Fifteen patients (31.3%) died during the hospital stay. Atrial fibrillation (83.3%) was the most common comorbidity. The median time from symptom onset to diagnosis was 13.0 (interquartile range, 4.75–24.0) h. Laparotomy, bowel resection, and thrombus embolectomy were performed in 41 (85.4%), 26 (54.2%), and 21 (43.8%) patients, respectively. A logistic regression model achieved 78.6% sensitivity in predicting cases not requiring bowel resection. Proximal occlusion was significantly associated with the requirement for bowel resection (P =.039). Conclusion: The time from symptom onset to diagnosis and occlusion site contributed to high sensitivity in determining the need for bowel resection in patients with acute SMA occlusion. Further prospective studies are warranted to investigate the clinical impact of this model.
KW - laparotomy
KW - necrosis
KW - prognosis
KW - retrospective study
KW - superior mesenteric artery
UR - http://www.scopus.com/inward/record.url?scp=85135934803&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135934803&partnerID=8YFLogxK
U2 - 10.1002/ags3.12614
DO - 10.1002/ags3.12614
M3 - Article
AN - SCOPUS:85135934803
SN - 2475-0328
VL - 7
SP - 175
EP - 181
JO - Annals of Gastroenterological Surgery
JF - Annals of Gastroenterological Surgery
IS - 1
ER -